Atlas Trials

Single Dose Study in Subjects With Severe Hemophilia A Comparing Pharmacokinetic Parameters for BAY81-8973 and Advate

Clinical trial NCT02483208 · COMPLETED

Trial details

NCT number
NCT02483208
Sponsor
Bayer
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Hemophilia A
Start date
2015-06-01
Primary completion
2015-07-01
Enrollment
18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.